Financials

  • Market Capitalization 44.63 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.03
Relación precio/flujo de caja
151.55

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4190
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.98 USD0.00%+4.26%+1.03%-39.13%47.63 M USD
4202
APLM
Apollomics Inc. - Class A Ordinary Shares
21.17 USD-1.53%-9.91%-8.67%+15.05%46.49 M USD
4228
TVGN
Tevogen Bio Holdings Inc. - Common Stock
6.68 USD-1.47%+2.45%-6.18%+840.85%43.50 M USD
4238
GRCE
Grace Therapeutics, Inc. - Common Stock
2.02 USD-2.88%-2.88%-8.60%-49.25%42.49 M USD

Noticias